Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon.

Cem TanrioverDuygu UckuMerve AkyolEnes CevikAsiye KanbayVikas S SridharDavid Z I CherneyMehmet Kanbay

Published in: Sleep & breathing = Schlaf & Atmung (2022)

SGLT2 inhibitors are prime pharmacological candidates for the treatment of OSA, and additional studies are needed to better explore mechanisms and outcomes unique to this population. Additionally, patients with OSA often have multiple comorbidities that are clinical indications for SGLT2 inhibitor therapy. Physicians should recognize and encourage the use of these agents in such patients.

Keyphrases

obstructive sleep apnea
positive airway pressure
primary care
end stage renal disease
ejection fraction
mesenchymal stem cells
type diabetes
prognostic factors
combination therapy
risk assessment
bone marrow
skeletal muscle
cell therapy
replacement therapy
smoking cessation
patient reported